488 related articles for article (PubMed ID: 30032993)
1. In vitro activity of antifungal combinations against planktonic and sessile cells of Candida albicans isolated from medical devices in an intensive care department.
Touil HFZ; Boucherit-Otmani Z; Boucherit K
J Mycol Med; 2018 Sep; 28(3):414-418. PubMed ID: 30032993
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of antifungal combinations against Candida albicans biofilms.
Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
[TBL] [Abstract][Full Text] [Related]
3. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.
Shuford JA; Piper KE; Steckelberg JM; Patel R
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):277-81. PubMed ID: 17141454
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Shinde RB; Chauhan NM; Raut JS; Karuppayil SM
Ann Clin Microbiol Antimicrob; 2012 Oct; 11():27. PubMed ID: 23035934
[TBL] [Abstract][Full Text] [Related]
5. Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.
Chatzimoschou A; Katragkou A; Simitsopoulou M; Antachopoulos C; Georgiadou E; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2011 May; 55(5):1968-74. PubMed ID: 21343465
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of anidulafungin, caspofungin, fluconazole and amphotericin B against biofilms and planktonic forms of Candida species isolated from blood culture in patients with hematological malignancies.
Malchikova A; Klyasova G
J Mycol Med; 2021 Sep; 31(3):101162. PubMed ID: 34147758
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
8. Quinacrine inhibits Candida albicans growth and filamentation at neutral pH.
Kulkarny VV; Chavez-Dozal A; Rane HS; Jahng M; Bernardo SM; Parra KJ; Lee SA
Antimicrob Agents Chemother; 2014 Dec; 58(12):7501-9. PubMed ID: 25288082
[TBL] [Abstract][Full Text] [Related]
9. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
Valentín A; Cantón E; Pemán J; Fernandez-Rivero ME; Tormo-Mas MA; Martínez JP
J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases.
Tobudic S; Lassnigg A; Kratzer C; Graninger W; Presterl E
Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353
[TBL] [Abstract][Full Text] [Related]
12. A novel assay of biofilm antifungal activity reveals that amphotericin B and caspofungin lyse Candida albicans cells in biofilms.
DiDone L; Oga D; Krysan DJ
Yeast; 2011 Aug; 28(8):561-8. PubMed ID: 21674619
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of amphotericin-B, voriconazole and caspofungin against Candida guilliermondii biofilms, isolated from dentals units water pipes, under different growth phases.
Mazari W; Boucherit-Otmani Z; Boucherit K
J Mycol Med; 2015 Mar; 25(1):57-62. PubMed ID: 25533329
[TBL] [Abstract][Full Text] [Related]
14. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
Seneviratne CJ; Jin LJ; Samaranayake YH; Samaranayake LP
Antimicrob Agents Chemother; 2008 Sep; 52(9):3259-66. PubMed ID: 18625775
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of the correlation between biofilm forming ability of urinary Candida isolates with the use of urinary catheters and change of antifungal susceptibility in the presence of biofilm].
Aslan H; Gülmez D
Mikrobiyol Bul; 2016 Apr; 50(2):256-65. PubMed ID: 27175498
[TBL] [Abstract][Full Text] [Related]
16. Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms.
Martins M; Henriques M; Lopez-Ribot JL; Oliveira R
Mycoses; 2012 Jan; 55(1):80-5. PubMed ID: 21668524
[TBL] [Abstract][Full Text] [Related]
17. Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry.
Maiolo EM; Furustrand Tafin U; Borens O; Trampuz A
Antimicrob Agents Chemother; 2014 May; 58(5):2709-17. PubMed ID: 24566186
[TBL] [Abstract][Full Text] [Related]
18. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles.
Shinde RB; Raut JS; Chauhan NM; Karuppayil SM
Braz J Infect Dis; 2013; 17(4):395-400. PubMed ID: 23602464
[TBL] [Abstract][Full Text] [Related]
20. Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.
Simitsopoulou M; Peshkova P; Tasina E; Katragkou A; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2013 Jun; 57(6):2562-70. PubMed ID: 23529739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]